View all information regarding the medicines that are manufactured by Cipla Ltd. (Respiratory) including its generic drug name, trade name, how to use, the price, and its composition.

After topping the Street's expectations with its Q3 earnings, Cipla announced plans to launch two key drugs in FY26—the respiratory drug Advair and the oncology drug Abraxane. Umang Vohra ...

Foracort is manufactured by Mumbai-based Cipla and is successful in reducing ... As toxic smog continues to choke cities, the rise of respiratory drugs like Foracort shows the urgent need for ...

The company reported a 48% year-on-year (y-o-y) jump in its consolidated net profit to ₹1,571 crore in October-December, while its total revenue from operations rose 8% to ₹7,073 crore. Analysts ...

Mumbai: Cipla has announced that the Company will invest approx. ZAR 900 million in equity share capital of Cipla Medpro ...

Cipla has launched an innovative combination of 3 HIV/AIDS drugs, Viraday that needs to be taken just once a day for effective treatment. Cipla has launched an innovative combination of 3 HIV/AIDS ...

Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Cipla expects to end the ongoing fiscal year ... which Vohra said was on the back of a seasonally-strong quarter, with higher respiratory drug sales. “The margin improves every time we sell ...

aided by demand for drugs used to treat respiratory and urology-related conditions. That more than made up for a 1% drop in sales in North America, Cipla's second-biggest market, and helped the ...

Cipla will receive the manufacturing know-how from Gilead Sciences to manufacture the drug at a commercial scale. The emergency use authorization (EUA) by the US FDA will facilitate broader use of ...